Jeffrey Thaxton, MD
Plastic Surgery · Charleston, WVNPI 1689755472
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,287 of the $3,774 with a category attached, or 60.6%. AbbVie accounts for 63.9% of it on its own, with 6 other manufacturers making up the rest.
Across 133 payments — averaging $28.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Musculoskeletal Transplant Foundation Inc.$706
- Mentor Worldwide LLC$288
- Sientra, Inc.$253
- Integra Lifesciences Corporation$55
- Endo Pharmaceuticals Inc.$44
- plus $16 from 1 others
What the payments were for
- Speaking & faculty fees$97626%
- Travel & lodging$51114%
- Food & beverage$2,28761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 97 | $2,413 |
| Musculoskeletal Transplant Foundation Inc. | 8 | $706 |
| Mentor Worldwide LLC | 14 | $288 |
| Sientra, Inc. | 9 | $253 |
| Integra Lifesciences Corporation | 2 | $55 |
| Endo Pharmaceuticals Inc. | 2 | $44 |
| TEI Biosciences Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic surgery providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 21 | $80 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $64 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Charleston
- William StewartCharleston$2K
- Donald SweitzerCharleston$1K
- Taylor SummersCharleston$367
- Theodore JacksonCharleston$352
- Daniel StewartCharleston$136
- William WoodCharleston$18
- James FernauHuntington$47K
- Mohamed BarryMartinsburg$12K
- Majed MaaloufMorgantown$8K
- William McClellanMorgantown$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.